Physician profile
Smith Blanc
NPI 1053644666
$6,047.22
in general payments reported to CMS, 2019-2025
20 companies · $1,324 in 2025
The $1,324 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $317 · 2021: $1,015 · 2022: $865 · 2023: $842 · 2024: $1,151 · 2025: $1,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,317.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,676.44 | 2021-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $757.15 | 2022-2025 | Infuse |
| Coopervision INC. | $604.89 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $555.42 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $411.63 | 2024-2025 | Xdemvy |
| Maculogix, INC. | $242.39 | 2019-2020 | |
| Abbvie INC. | $216.69 | 2022-2025 | |
| New World Medical,INC. | $211.09 | 2023-2025 | Clearpath, Ahmed Glaucoma Valve, Via360 |
| Glaukos Corporation | $174.02 | 2024 | Idose |
| Optovue, INC. | $153.87 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $125.00 | 2021 | |
| Dompe US, INC. | $121.82 | 2025 | Oxervate |
| Horizon Therapeutics Plc | $119.36 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $118.58 | 2022 | |
| Alcon Vision LLC | $105.44 | 2022-2024 | Total30 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionix USA, INC | $99.75 | 2022 | |
| Optos, INC. | $98.28 | 2021 | |
| Oyster Point Pharma, INC. | $98.08 | 2023-2024 | Tyrvaya |
| Lkc Technologies, INC. | $89.54 | 2025 | |
| Allergan, INC. | $67.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smith Blanc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.